Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.
about
Decoding protein networks during virus entry by quantitative proteomicsThe interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replicationVirus-host interactomics: new insights and opportunities for antiviral drug discoveryInterplay between influenza A virus and host factors: targets for antiviral intervention.Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysisAdvances in antivirals for non-influenza respiratory virus infections.Positive selection of primate genes that promote HIV-1 replication.Benchmarking selected computational gene network growing tools in context of virus-host interactions.Influenza virus-host interactome screen as a platform for antiviral drug developmentIdentification of acetyltransferase genes (HAT1 and KAT8) regulating HBV replication by RNAi screening.Host genetics of severe influenza: from mouse Mx1 to human IRF7High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay.Influenza virus-host interactomes as a basis for antiviral drug development.An integrative approach for a network based meta-analysis of viral RNAi screensiTRAQ-based quantitative proteomics reveals important host factors involved in the high pathogenicity of the H5N1 avian influenza virus in mice.Role of Host Genes in Influenza Virus Replication.Viruses and interactomes in translation.
P2860
Q27469058-46B31423-B100-4C48-BD43-054678FE2C01Q28115759-A77393A6-5769-4DA6-905A-65B3590A326CQ28652236-A6374ED6-9F38-48A5-BCDB-1F802179B2D7Q30375026-059384F5-B426-4607-89BA-9390DDC15749Q30385012-536300E8-AEE4-4728-A1EF-9E3C715A8802Q30457132-FF997E1D-814D-486C-AC6B-3F8B92E128C2Q33637979-41684941-D250-4958-8D82-74913591CEF0Q33918669-87929F36-5857-4DC6-A46D-AC1531552F50Q35672215-B72C0829-FDF0-47E8-BADF-D659AF32C08DQ36346801-605F7A6F-964B-4948-AC21-7E3D278E140FQ36522870-F56D091E-9812-46C2-A7F0-5E1BE4F0B39BQ37202090-4FF562D2-AB72-4707-93F9-42914F6EEEFBQ37737812-1EA43280-8D31-46E4-A617-DD9B8BC4C8ABQ38416102-DAE4F2A8-529F-4CEE-B1DE-54E36D41C912Q38725108-974966CC-2573-4233-A888-51209AA1DCB8Q39393272-04176A7D-1D93-42B8-9682-BF43157A3BB2Q42234001-97921447-B6DC-48F6-A286-8EECACAB9810
P2860
Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Genetic screens for the contro ...... ta-analysis to drug discovery.
@en
Genetic screens for the contro ...... ta-analysis to drug discovery.
@nl
type
label
Genetic screens for the contro ...... ta-analysis to drug discovery.
@en
Genetic screens for the contro ...... ta-analysis to drug discovery.
@nl
prefLabel
Genetic screens for the contro ...... ta-analysis to drug discovery.
@en
Genetic screens for the contro ...... ta-analysis to drug discovery.
@nl
P2093
P2860
P356
P1433
P1476
Genetic screens for the contro ...... eta-analysis to drug discovery
@en
P2093
Anne Aublin-Gex
Benoît de Chassey
Laurène Meyniel-Schicklin
Patrice André
P2860
P304
P356
10.1039/C2MB05416G
P50
P577
2012-02-03T00:00:00Z